JP Morgan Chase’s Acadia Healthcare ACHC Stock Holding History
Bought
Maintained
Sold
Other funds holding ACHC
KCM
VPM
DM
DCM
ABI
VCM
JP Morgan Chase's ACHC Position: Q1 2026 in Review
JP Morgan Chase reduced its Acadia Healthcare (ACHC) stake by 55% in Q1 2026, selling an estimated $2.06M and leaving 93,240 shares worth $2.13M. The position accounts for ﹤0.01% of the portfolio, ranked #4056.
JP Morgan Chase first reported a position in ACHC in Q2 2013 and has held it in 52 quarters since. The position peaked at $341M in Q2 2017. 295 funds tracked by Wall St. Rank hold ACHC as of Q1 2026.
- JP Morgan Chase held 93,240 shares of Acadia Healthcare worth $2.13M as of Q1 2026.
- JP Morgan Chase sold 113,593 Acadia Healthcare shares in Q1 2026, an estimated $2.06M.
- Acadia Healthcare made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #4056 holding.
- JP Morgan Chase first reported a position in Acadia Healthcare in Q2 2013 and has held it in 52 quarters since.
- JP Morgan Chase's Acadia Healthcare position peaked at $341M in Q2 2017.
- 295 funds tracked by Wall St. Rank held Acadia Healthcare as of Q1 2026.
Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.